Tecentriq 1200 mg / 20 ml (Atezolizumab 1200 mg / 20 ml) by Roche.
Indications: Urothelial carcinoma, NSCLC, small-cell lung cancer, hepatocellular carcinoma and triple-negative breast cancer (per SmPC).
Administration: Intravenous infusion of 1200 mg every 3 weeks.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Atezolizumab 1200 mg / 20 ml — anti-PD-L1 monoclonal antibody. |
| Strength & pack | 1 vial of 20 ml. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |